Kolexia
Uwer Lionel Oncologie médicale
Uwer Lionel
Oncologie médicale
Institut de cancérologie de Lorraine
Vandoeuvre-lès-Nancy, France
114 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Métastase tumorale Tumeur du sein de l'homme Tumeurs du sein triple-négatives Tumeurs du poumon Récidive tumorale locale Carcinome pulmonaire à petites cellules Carcinomes Mésothéliome

Collaborateurs

Voir plus
Ferrero Jean Marc
Ferrero Jean Marc
Centre Antoine Lacassagne, Nice, France
Petit Thierry
Petit Thierry
Centre Paul Strauss, Strasbourg, France
Goncalves Anthony
Goncalves Anthony
Centre Paoli-Calmettes, Marseille, France
Levy Christelle
Levy Christelle
Centre François-Baclesse, Caen, France

Industries

Voir plus
Lilly
30 collaboration(s)
Dernière en 2023
Pfizer
19 collaboration(s)
Dernière en 2023
AstraZeneca
13 collaboration(s)
Dernière en 2023
Seagen
6 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
EFACog: Evaluation of the Feasibility of Personalized and Preventive Support for COGnitive Complaints, by a Paramedical Caregiver in Women Suffering From Non-Metastatic Breast Cancer, Requiring Chemotherapy (EFACog).
Essai Clinique (Institut de cancérologie de Lorraine)   04 mars 2024
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.
The oncologist   11 octobre 2023
EVONAIL: Study of the Effectiveness of the Film-forming Solution Evonail® Versus Placebo in the Prevention of Nail Damage Induced by Docetaxel in Patients With Breast Cancer.
Essai Clinique (Institut de cancérologie de Lorraine)   26 septembre 2023
Teasing - Conférence François Bourgognon - 30 juin 2023
Youtube @ Institut de Cancérologie de Lorraine - ICL   23 juin 2023
Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort.
European journal of cancer (Oxford, England : 1990)   07 juin 2023
Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation.
British journal of cancer   03 avril 2023
ESME-MBC: Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform: Evolution of the Therapeutic Care in Metastatic Breast Cancer Across the French Comprehensive Cancer Centers From 2008
Essai Clinique (Seagen)   16 mars 2023
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
BMC medicine   08 mars 2023
CHACRY-1501: Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation (CHACRY-1501)
Essai Clinique (Centre Oscar-Lambret)   13 février 2023
Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study.
Cancers   13 février 2023